Wall Street firm Cravath, Swain & Moore had a bumper start to the Spring season in March, successful negotiating two deals totalling $15.5 billion. Also involved in the transactions were Paul, Weiss, Rifkind, Wharton & Garrison and Californian firm Heller Ehrman White & McAuliffe. Cravath, Swaine & Moore acted for healthcare product maker Johnson & Johnson in April on its agreed a $10.5 billion merger with research-based pharmaceuticals company ALZA. Heller Ehrman White & McAuliffe acted for ALZA in a transaction which saw ALZA shareholders receive a fixed exchange ratio of 0.49 shares of Johnson & Johnson common stock for each share of ALZA in a tax-free transaction.
April 30 2001